Dual oncogenic roles of TPD52 and TPD52L2 in gastric cancer progression via PI3K/AKT activation and immunosuppressive microenvironment remodeling
Briefings in Functional Genomics · 15.01.2025 · 24
DOI: 10.1093/bfgp/elaf015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Briefings in Functional Genomics, online erschienen am 19.09.2025. Verfasst von Hailong Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: The First Clinical Medical College, Gansu University of Chinese Medicine, No. 35 Dingxi East Road, Chengguan District, Lanzhou City, Gansu Province, …. Hauptthemen laut MEDLINE: Neoplasm Proteins, Stomach Neoplasms, Tumor Microenvironment. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shenzhen Medical Key Discipline Construction Fund, Gansu Province Health Industry Research Plan Project, Joint Research Fund of the Provincial Science and Technology Program of Gansu Province.
Abstract (Originalsprache)
Aim
TPD52 (tumor protein D52) and TPD52L2 (tumor protein D52-like 2), members of the TPD52 gene family, have been implicated in multiple malignancies. However, their roles in gastric cancer (GC) remain elusive. Herein, we integrated multiomics analyses and experimental validation to elucidate their prognostic and functional significance in GC.
Methods
Utilizing The Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO), and tissue microarray datasets, we analyzed TPD52/TPD52L2 expression patterns in patients with GC. Survival analysis, Cox regression, and nomogram construction were performed to assess prognostic value. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes functional enrichment analysis and immune infiltration evaluation (Cell-type Identification By Estimating Relative Subsets Of RNA Transcripts/Estimation of STromal and Immune cells in MAlignant Tumour tissues using Expression data) (CIBERSORTx/ESTIMATE) were conducted to explore the molecular mechanisms involved. In vitro experiments (cell proliferation, migration, invasion, and apoptosis assays) were performed via lentivirus-mediated gene knockdown in gastric cancer cell lines AGS and MKN45 cells.
Results
TPD52 and TPD52L2 were significantly overexpressed in GC tissues compared with their normal counterparts. Elevated TPD52L2 expression was significantly associated with advanced Tumor, Node, Metastasis (TNM) stage and independently predicted reduced overall survival according to multivariate Cox regression. Multivariate analysis identified TPD52L2 as an independent prognostic factor. Diagnostic Receiver Operating Characteristic (ROC) curves yielded area under the curve values of 0.813 (TPD52) and 0.807 (TPD52L2). The results of functional experiments suggested that TPD52/TPD52L2 knockdown inhibited proliferation, migration, G0/G1 arrest, and induced apoptosis. Mechanistically, TPD52/TPD52L2 silencing suppressed PI3K/Akt serine/threonine kinase (AKT)/mammalian target of rapamycin (mTOR) signaling and epithelial–mesenchymal transition marker expression.
Conclusion
TPD52 and TPD52L2 are promising prognostic biomarkers in GC, with TPD52L2 exhibiting greater clinical relevance. Targeting these proteins may disrupt oncogenic signaling pathways and enhance immunotherapy efficacy, warranting further investigation in clinical trials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The First Clinical Medical College, Gansu University of Chinese Medicine, No. 35 Dingxi East Road, Chengguan District, Lanzhou City, Gansu Province, Lanzhou 730000, P. R. China.
- Department of Scientific & Research, Affiliated Hospital of Gansu University of Chinese Medicine, No. 732 Jiayuguan West Road, Chengguan District, Lanzhou City, Lanzhou 730000, P. R. China.
- Department of General Practice, Luohu Clinical Institute of Shantou University Medical College, No. 47 Youyi Road, Luohu District, Shenzhen, Guangdong Province, Shenzhen 518000, P. R. China.
- Key Laboratory of Gansu Provincial Prescription Mining and Innovative Translational Laboratory, Gansu University of Chinese Medicine, No. 35 Dingxi East Road, Chengguan District, Lanzhou City, Gansu Province, Lanzhou 73…
- Department of Gastroenterology, Xihua County People's Hospital, No. 15 Jicheng Road, Chengguan Town, Xihua County, Zhoukou City, Hennan Province, Zhoukou 466600, P. R. China.
ORCID-Profile: Hailong Li, Xiaqing Gao, Shuping Qiu
Förderung
- Shenzhen Medical Key Discipline Construction Fund
- Gansu Province Health Industry Research Plan Project
- Joint Research Fund of the Provincial Science and Technology Program of Gansu Province
Zitieren
APA
Li, H., Gao, X., Guo, S., Gao, S., Yang, C., Su, R., Jing, Z., Qiu, S., Tang, P., & Han, J. (2025). Dual oncogenic roles of TPD52 and TPD52L2 in gastric cancer progression via PI3K/AKT activation and immunosuppressive microenvironment remodeling. Briefings in Functional Genomics, 24. https://doi.org/10.1093/bfgp/elaf015
Vancouver
Li H, Gao X, Guo S, Gao S, Yang C, Su R, et al. Dual oncogenic roles of TPD52 and TPD52L2 in gastric cancer progression via PI3K/AKT activation and immunosuppressive microenvironment remodeling. Briefings in Functional Genomics. 2025;24. doi:10.1093/bfgp/elaf015
BibTeX
@article{Li2025,
author = {Li, Hailong and Gao, Xiaqing and Guo, Shuangming and Gao, Shenfei and Yang, Chunting and Su, Rong and Jing, Zhe and Qiu, Shuping and Tang, Ping and Han, Jing},
title = {Dual oncogenic roles of TPD52 and TPD52L2 in gastric cancer progression via PI3K/AKT activation and immunosuppressive microenvironment remodeling},
journal = {Briefings in Functional Genomics},
year = {2025},
volume = {24},
doi = {10.1093/bfgp/elaf015}
}
EUVIMED